“…In many of these models of acute critical illness, treatment with ethyl pyruvate down-regulates the expression of various pro-inflammatory genes, including inducible nitric oxide synthase (iNOS), tumor necrosis factor, cyclooxygenase-2, and interleukin (IL)-6 (Yang et al, , 2003(Yang et al, , 2004Uchiyama et al, 2003). Similarly, ethyl pyruvate inhibits IL-6 and iNOS expression, nitric oxide production, and/or secretion of the pro-inflammatory protein HGMB1 by immunostimulated Caco-2 human enterocytelike cells or lipopolysaccharide-stimulated RAW 264.7 murine macrophage-like cells (Ulloa et al, 2002;Sappington et al, 2003a,b;Song et al, 2004). These latter findings support the view that ethyl pyruvate has activity as an anti-inflammatory agent; however, the molecular mechanisms underlying the anti-inflammatory effects of ethyl pyruvate remain to be elucidated.…”